Spectral Medical Inc. (OTCMKTS:EDTXF) Short Interest Up 8.8% in March

Spectral Medical Inc. (OTCMKTS:EDTXF) saw a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 71,500 shares, an increase of 8.8% from the March 15th total of 65,700 shares. Based on an average daily trading volume, of 86,000 shares, the days-to-cover ratio is presently 0.8 days.

Spectral Medical Price Performance

Shares of OTCMKTS EDTXF remained flat at $0.32 during mid-day trading on Tuesday. Spectral Medical has a fifty-two week low of $0.17 and a fifty-two week high of $0.50. The company has a market cap of $90.07 million, a PE ratio of -8.08 and a beta of 0.81. The business’s 50 day moving average is $0.37 and its 200 day moving average is $0.32.

Spectral Medical (OTCMKTS:EDTXF) last announced its quarterly earnings results on Thursday, March 28th. The company reported ($0.02) EPS for the quarter. The firm had revenue of $0.27 million during the quarter.

Spectral Medical Company Profile

Spectral Medical Inc, together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.